Top section
Top section
Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
The most successful investment banks must strive for excellence in managing people
More articles
More articles
More articles
-
Barclays has poached a leading real estate investment banker from JP Morgan in a move rivals say could lead to shift in banking relationships. -
Animal healthcare company Huvepharma has opened the books on its €463m IPO on the Amsterdam Stock Exchange.
-
Morgan Stanley managing director Tobias Åkermark is leaving the US firm to become head of Nordic banking and country CEO for Sweden at Barclays.
-
Chaoju Eye Care Holdings is gauging investor appetite for a HK$1.81bn ($233m) listing on the Hong Kong Stock Exchange, becoming the latest healthcare related company to seek an IPO.
-
Chinese technology companies are flocking back to the US for IPOs after months of poor market conditions and the regulatory crackdown on the sector brought deal flow to a near halt. There is more on the way too, as issuers look to wrap up deals before the summer slowdown. Jonathan Breen reports.
-
Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.
Sub-sections
shared comment list
